Routine delays: the cancer services struggling to treat patients on time Demand for cancer treatment continues to rise while workforce numbers fall, leaving NHS cancer services calling for help as they enter “crisis management”.
Copy link to page Download PDF
Wes Mountain/The Pharmaceutical Journal
Responses to a survey carried out by the British Oncology Pharmacy Association (BOPA) on the state of anticancer therapy provision in the UK make for difficult reading[1] .
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Last updated 7 December 2023 14:23
